FDA Adverse Event Injury Summary report: N

CP1150 MAGNET (STRENGTH 4 (I))

MDR report key: 14784708 · Received June 23, 2022

Report

Report Number
6000034-2022-01818
Event Type
Injury
Date Received
June 23, 2022
Date of Event
January 4, 2022
Report Date
June 1, 2022
Manufacturer
COCHLEAR LIMITED
Product Code
MCM
UDI-DI
09321502036573
PMA / PMN Number
P970051
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS SUBMITTED ON JUNE 23, 2022

Additional Manufacturer Narrative · 0

CORRECTION: THE DEVICE DETAILS SUBMITTED IN THE PREVIOUS REPORT ON JUNE 23, 2022, WERE INCORRECT. THE DETAILS FOR SECTION D HAVE BEEN UPDATED ACCORDINGLY. THIS REPORT IS SUBMITTED ON JULY 26, 2022.

Description of Event or Problem · 0

PER THE CLINIC, THE PATIENT EXPERIENCED PAIN AND THE BUILD-UP OF FLUID (EFFUSION) AND AN INFECTION AT THE IMPLANT SITE WHICH WAS TREATED WITH A TOPICAL ANTIBIOTIC. THE IMPLANT REMAINS IN-SITU.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
331670 CP1150 MAGNET (STRENGTH 4 (I)) NUCLEUS 24 COCHLEAR IMPLANT SYSTEM MCM COCHLEAR LIMITED CP1150 MAGNET N/A 09321502036573

Patients

Seq Age Sex Outcome Treatment
1 50 YR Female Required Intervention